BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND PMS2, HNPCC4, 5395, ENSG00000122512, H_DJ0042M02_9, PMSL2, PMS2CL AND Prognosis
83 results:

  • 1. Multiple pathological fractures and muscle atrophy caused by a parathyroid carcinoma with postoperative hungry bone syndrome: A case report.
    Liu Q; Zhang Y; Ma D; Gengzhi H; Maimaiti Y; Chen Q; Ma Z
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2047. PubMed ID: 38577726
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Social Vulnerability Association with thyroid cancer Disparities in the United States.
    Fei-Zhang DJ; Verma R; Arimoto R; Lawrence AS; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
    Thyroid; 2024 Feb; 34(2):225-233. PubMed ID: 38069566
    [No Abstract]    [Full Text] [Related]  

  • 3. Is unicentric familial papillary thyroid microcarcinoma different from multicentric?
    Ríos A; Ruiz-Pardo J; Balaguer-Román A; Puñal JA; Moreno P; Mercader E; Ferrero E; Morlán MA; Martín J; Durán M; Bravo JM; Casanova D; Salvador-Egea MP; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
    Endocrine; 2023 Dec; 82(3):613-621. PubMed ID: 37490266
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Assessment of Social Vulnerability in Pediatric Head and Neck cancer Care and prognosis in the United States.
    Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
    JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical Features and prognosis Analysis of Hormone Receptor-Positive, HER2-Negative Breast cancer with Differential Expression Levels of Estrogen and Progesterone Receptors: A 10-Year Retrospective Study.
    Liu J; Gan M; Lin Z; Deng Q; Deng J; Zeng B; Shi Y; Ming J
    Breast J; 2022; 2022():5469163. PubMed ID: 36531979
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Medullary carcinoma of the colon: A comprehensive analysis of the National cancer Database.
    Jabbal IS; Nagarajan A; Rivera C; Yaghi M; Liang H; Nahleh Z; Bejarano P; Berho M; Wexner S
    Surg Oncol; 2022 Dec; 45():101856. PubMed ID: 36446307
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Disease-Specific Survival Trends for Patients Presenting with Differentiated thyroid cancer and Distant Metastases in the United States, 1992-2018.
    Wilhelm A; Conroy PC; Calthorpe L; Shui AM; Kitahara CM; Roman SA; Sosa JA
    Thyroid; 2023 Jan; 33(1):63-73. PubMed ID: 36413032
    [No Abstract]    [Full Text] [Related]  

  • 8. Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study.
    Ríos A; Rodríguez MA; Puñal JA; Moreno P; Mercader E; Ferrero E; Ruiz-Pardo J; Morlán MA; Martín J; Durán-Poveda M; Bravo JM; Casanova D; Egea MPS; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
    Langenbecks Arch Surg; 2022 Dec; 407(8):3631-3642. PubMed ID: 36251077
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. NUTM1 -rearranged Carcinoma of the thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
    Barletta JA; Gilday SD; Afkhami M; Bell D; Bocklage T; Boisselier P; Chau NG; Cipriani NA; Costes-Martineau V; Ghossein RA; Hertzler HJ; Kramer AM; Limaye S; Lopez CA; Ng TL; Weissferdt A; Xu B; Zhang S; French CA
    Am J Surg Pathol; 2022 Dec; 46(12):1706-1715. PubMed ID: 36040068
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Spread of lymph node metastasis and adjuvant therapy for distal cholangiocarcinoma.
    Kurahara H; Mataki Y; Idichi T; Kawasaki Y; Mori S; Sasaki K; Arigami T; Nakajo A; Fukukura Y; Higashi M; Ohtsuka T
    Int J Clin Oncol; 2022 Jul; 27(7):1212-1221. PubMed ID: 35543887
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic thyroid cancer.
    Lee NY; Riaz N; Wu V; Brinkman T; Tsai CJ; Zhi W; Fetten J; Ho A; Wong RJ; Ghossein R; Tuttle M; Fagin J; Pfister DG; Sherman E
    Thyroid; 2022 Jul; 32(7):799-806. PubMed ID: 35521657
    [No Abstract]    [Full Text] [Related]  

  • 12. Correlation of mismatch repair deficiency with clinicopathological features and programmed death-ligand 1 expression in thyroid carcinoma.
    Qiao PP; Tian KS; Han LT; Ma B; Shen CK; Zhao RY; Zhang Y; Wei WJ; Chen XP
    Endocrine; 2022 Jun; 76(3):660-670. PubMed ID: 35366156
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
    Sahin I; Saat H
    Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
    [No Abstract]    [Full Text] [Related]  

  • 14. Characterization of Subtypes of BRAF-Mutant Papillary thyroid cancer Defined by Their thyroid Differentiation Score.
    Boucai L; Seshan V; Williams M; Knauf JA; Saqcena M; Ghossein RA; Fagin JA
    J Clin Endocrinol Metab; 2022 Mar; 107(4):1030-1039. PubMed ID: 34897468
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Influence of Emotions on Treatment Decisions About Low-Risk thyroid cancer: A Qualitative Study.
    Pitt SC; Saucke MC; Roman BR; Alexander SC; Voils CI
    Thyroid; 2021 Dec; 31(12):1800-1807. PubMed ID: 34641715
    [No Abstract]    [Full Text] [Related]  

  • 16. Parotid saliva
    Rovera A; Hector M; Anderson P
    Spec Care Dentist; 2022 Jan; 42(1):80-85. PubMed ID: 34293207
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Accuracy of the Lymph Node Yield in Surgery for Papillary thyroid cancer in Children.
    Yap A; Shui A; Gosnell J; Huang CY; Sosa JA; Roman S
    World J Surg; 2021 Oct; 45(10):3092-3098. PubMed ID: 34180009
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Oncogenic Mutations in PI3K/AKT/mTOR Pathway Effectors Associate with Worse prognosis in
    Pappa T; Ahmadi S; Marqusee E; Johnson HL; Nehs MA; Cho NL; Barletta JA; Lorch JH; Doherty GM; Lindeman NI; Alexander EK; Landa I
    Clin Cancer Res; 2021 Aug; 27(15):4256-4264. PubMed ID: 34088725
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic thyroid Carcinoma.
    Qin Y; Wang JR; Wang Y; Iyer P; Cote GJ; Busaidy NL; Dadu R; Zafereo M; Williams MD; Ferrarotto R; Gunn GB; Wei P; Patel K; Hofmann MC; Cabanillas ME
    Thyroid; 2021 Aug; 31(8):1235-1243. PubMed ID: 33599171
    [No Abstract]    [Full Text] [Related]  

  • 20. Distant Metastases From Childhood Differentiated thyroid Carcinoma: Clinical Course and Mutational Landscape.
    Nies M; Vassilopoulou-Sellin R; Bassett RL; Yedururi S; Zafereo ME; Cabanillas ME; Sherman SI; Links TP; Waguespack SG
    J Clin Endocrinol Metab; 2021 Mar; 106(4):e1683-e1697. PubMed ID: 33382403
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.